ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALKS Alkermes PLC

24.26
0.19 (0.79%)
After Hours
Last Updated: 17:30:25
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,245,764
Bid Price 23.58
Ask Price 25.11
News -
Day High 24.63

Low
22.01

52 Week Range

High
33.71

Day Low 24.06
Company Name Stock Ticker Symbol Market Type
Alkermes PLC ALKS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.19 0.79% 24.26 17:30:25
Open Price Low Price High Price Close Price Prev Close
24.09 24.06 24.63 24.26 24.07
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16,823 1,245,764 $ 24.41 $ 30,410,051 - 22.01 - 33.71
Last Trade Time Type Quantity Stock Price Currency
16:02:56 priorref 450 $ 24.26 USD

Alkermes (ALKS) Options Flow Summary

Overall Flow

Bearish

Net Premium

0

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Alkermes PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.05B 167.08M - 1.66B 355.76M 2.13 11.39
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alkermes News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ALKS Message Board. Create One! See More Posts on ALKS Message Board See More Message Board Posts

Historical ALKS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.0224.6323.4823.901,938,1840.241.00%
1 Month27.4527.5623.4825.451,885,096-3.19-11.62%
3 Months28.2632.8823.4827.902,058,082-4.00-14.15%
6 Months27.2532.8822.0126.892,330,630-2.99-10.97%
1 Year29.3033.7122.0127.931,943,411-5.04-17.20%
3 Years21.1033.7120.7626.761,650,5623.1614.98%
5 Years33.5034.9711.9824.081,547,498-9.24-27.58%

Alkermes Description

Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Your Recent History

Delayed Upgrade Clock